tradingkey.logo

LENSAR Inc

LNSR
11.440USD
-1.080-8.63%
Fechamento 11/06, 16:00ETCotações atrasadas em 15 min
136.51MValor de mercado
PerdaP/L TTM

Mais detalhes de LENSAR Inc Empresa

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.

Informações de LENSAR Inc

Código da empresaLNSR
Nome da EmpresaLENSAR Inc
Data de listagemSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis
Número de funcionários140
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 21
Endereço2800 Discovery Drive
CidadeORLANDO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32826
Telefone18885367271
Sitehttps://www.lensar.com/
Código da empresaLNSR
Data de listagemSep 21, 2020
CEOMr. Nicholas T. (Nick) Curtis

Executivos da empresa LENSAR Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-8.36%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-1.34%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-2.99%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7.93%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-8.36%
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
7.75M
63.07%
Europe
2.41M
19.63%
Asia (excluding South Korea)
1.87M
15.21%
South Korea
181.00K
1.47%
Other
76.00K
0.62%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sex, 15 de ago
Atualizado em: sex, 15 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
4.72%
Link (William J)
4.55%
BlackRock Institutional Trust Company, N.A.
4.48%
Outro
70.41%
Investidores
Investidores
Proporção
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
4.72%
Link (William J)
4.55%
BlackRock Institutional Trust Company, N.A.
4.48%
Outro
70.41%
Tipos de investidores
Investidores
Proporção
Investment Advisor
23.51%
Individual Investor
19.70%
Hedge Fund
13.36%
Investment Advisor/Hedge Fund
7.08%
Bank and Trust
1.52%
Pension Fund
1.48%
Research Firm
0.66%
Outro
32.68%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
148
5.68M
47.60%
+154.65K
2025Q2
124
7.77M
65.87%
+342.80K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
2023Q3
96
7.03M
62.74%
-797.20K
2023Q2
103
7.07M
63.18%
-1.15M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
North Run Capital, LP
1.10M
9.22%
--
--
Mar 23, 2025
Curtis (Nicholas T)
792.29K
6.64%
--
--
May 15, 2025
Brandes Investment Partners, L.P.
563.58K
4.72%
+18.89K
+3.47%
Jun 30, 2025
Link (William J)
550.64K
4.61%
+7.37K
+1.36%
May 23, 2025
BlackRock Institutional Trust Company, N.A.
534.89K
4.48%
+383.07K
+252.33%
Jun 30, 2025
The Vanguard Group, Inc.
506.16K
4.24%
+63.66K
+14.39%
Jun 30, 2025
Connaughton (Alan B.)
279.22K
2.34%
--
--
May 15, 2025
La Française AM
251.40K
2.11%
+125.40K
+99.52%
Jun 30, 2025
Lindstrom (Richard L)
246.41K
2.06%
+7.37K
+3.08%
May 23, 2025
Tudor Investment Corporation
236.71K
1.98%
-40.29K
-14.55%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Ver Mais
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.02%
iShares Micro-Cap ETF
Proporção0.02%
iShares Russell 2000 Growth ETF
Proporção0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.01%
Franklin US Small Cap Multifactor Index ETF
Proporção0.01%
iShares Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Global X Russell 2000 ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI